Previous studies using LysM–Cre to drive TFEB overexpression in myeloid cells revealed protection against atherosclerosis, diet-induced obesity, and insulin resistance.25 The gene discussed is TFEB; the disease is obesity due to melanocortin 4 receptor deficiency.